Pfizer News | finanzen.ch

Pfizer Aktie VALOR 962004 / ISIN US7170811035

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Trading-Depot

Aktion

Portfolio

Watchlist

28.11.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
20.11.22	Das sind die grössten Tesla-Aktionäre nach Musks Aktienverkauf (finanzen.ch) Elon Musk hat sich in jüngerer Zeit immer wieder von grossen Tesla-Aktienpaketen getrennt. Wie viele Anteile besitzt der Milliardär jetzt noch?» mehr
18.11.22	4: Statement of changes in beneficial ownership of securities (RSS)
17.11.22	Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection (RSS)
16.11.22	Form 4 78003 (RSS)
11.11.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
10.11.22	Tilray Medical Brings Canada’s Iconic Cannabis Brand Good Supply to Germany (RSS)
09.11.22	Form 10-Q 78003 (RSS)
04.11.22	Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine (RSS)
03.11.22	Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma (Businesswire)
03.11.22	Pfizer and BioNTech Initiate Phase 1 Study of Single Dose mRNA-Based Combination Vaccine Candidate for Influenza and COVID-19 (RSS)
01.11.22	PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK (Businesswire)
01.11.22	Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate (Businesswire)
01.11.22	Form 8-K 78003 (RSS)
19.10.22	Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 6 Months to less than 5 Years in the European Union (RSS)
18.10.22	Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments at IDWeek 2022 (Businesswire)
13.10.22	Terrapin Beer Co. Celebrates 23 Years of Craft Beer and Environmental Stewardship with Terraprint Initiative and Orvis Partnership (RSS)
13.10.22	Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older (Businesswire)
12.10.22	Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age (RSS)
12.10.22	Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age (Businesswire)
07.10.22	Tilray Beverages Launches Cruisies, a New Line of Ready-To-Drink Cocktails (RSS)
05.10.22	Pfizer Completes Acquisition of Global Blood Therapeutics (Businesswire)
04.10.22	Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial (Businesswire)
03.10.22	Pfizer Completes Acquisition of Biohaven Pharmaceuticals (Businesswire)
28.09.22	Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age (RSS)
27.09.22	Hohe Unsicherheit am Markt: Welche Aktien Goldman Sachs jetzt empfiehlt (finanzen.ch) Angesichts der hohen Unsicherheit am Markt raten viele Strategen zum Einstieg in Value-Titel. Auch Goldman Sachs hält Titel aus diesem Segment für lohnenswert. Besonders die zehn am meisten untergewichteten Aktien aus dem Value-Bereich sollten für Anleger einen Blick wert sein.» mehr
26.09.22	Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age (RSS)
26.09.22	Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age (Businesswire)
22.09.22	Pfizer Declares Fourth-Quarter 2022 Dividend (Businesswire)
22.09.22	Pfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income Countries (Businesswire)
20.09.22	Pfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with Analysts (Businesswire)
19.09.22	Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union (Businesswire)
16.09.22	Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union (RSS)
15.09.22	Pfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents (Businesswire)
14.09.22	Pfizer Invites Public to View and Listen to Webcast of Analyst and Investor Call to Review Oral GLP-1 Data Presented at European Association for the Study of Diabetes (EASD) 2022 (Businesswire)
14.09.22	Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine (Businesswire)
12.09.22	Tilray Brands Reports Q3 Fiscal 2025 Financial Results (RSS)
12.09.22	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union (Businesswire)
09.09.22	FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata (Businesswire)
07.09.22	FDA Grants Breakthrough Therapy Designation to Pfizer’s Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women (Businesswire)
06.09.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
06.09.22	Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Climate Action (Businesswire)
01.09.22	Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences (Businesswire)
01.09.22	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union (RSS)
01.09.22	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union (Businesswire)
31.08.22	Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older (Businesswire)
31.08.22	Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older (RSS)
30.08.22	So sieht die Aktionärsstruktur beim Corona-Impfstoffentwickler BioNTech aus (finanzen.ch) Der Corona-Impfstoff aus dem Hause BioNTech hat nicht nur die Börse euphorisch gestimmt, sondern auch den Mitgründer und CEO des Konzerns, Ugur Sahin, in die globale Rangliste der Superreichen katapultiert.» mehr
26.08.22	Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market (RSS)
25.08.22	Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate (Businesswire)

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Holcim	65.66	1.42 %	K V
Roche Hldg G	263.10	1.35 %	K V
Geberit	633.20	1.34 %	K V
Lonza Grp	581.00	1.18 %	K V
ABB	54.10	1.16 %	K V
Swisscom	567.50	-0.18 %	K V
Sika	196.45	-0.28 %	K V
UBS Group	30.74	-0.71 %	K V
CieFinRichemont	135.75	-0.91 %	K V

mehr

09:42		Bayer-Aktie im Fokus: Bayer stellt Anträge auf Marktzulassung für Pionier-Herbizid Icafolin
09:21		Sanofi-Aktie dennoch schwächer: Sanofi nach starkem Quartal - Unternehmen wird optimistischer
30.07.25		Sandoz-Aktie steigt: Sandoz will Just-Evotec Biologics übernehmen
30.07.25		Dow Jones 30 Industrial-Wert Johnson Johnson-Aktie: So viel Gewinn hätte ein Investment in Johnson Johnson von vor einem Jahr eingefahren
30.07.25		Novartis-Aktie in Grün: Leukämie-Mittel Scemblix in Kanada für weiteren Einsatz zugelassen
30.07.25		Aktien-Tipp Merck-Aktie: JP Morgan Chase & Co. bewertet Anteilsschein in neuer Analyse
30.07.25		GSK-Aktie in Grün: GSK konkretisiert 2025-Ziele
30.07.25		EVOTEC-Aktie höher: EVOTEC und Sandoz planen strategischen Technologiedeal über 300 Millionen Dollar